Major Depressive Disorder Rethinking and Understanding Recent Discoveries 1st Edition by Yong Ku Kim 9813360445 9789813360440

Part I. Re-thinking Depression from a Network Perspective

1. Phenotype Network and Brain Structural Covariance Network of Major Depression

2. Task MRI-Based Functional Brain Network of Major Depression

3. White Matter-Based Structural Brain Network of Major Depression

4. The Application of a Machine Learning-Based Brain Magnetic Resonance Imaging Approach in Major Depression

5. “Common Currency” Between Experience and Brain: Spatiotemporal Psychopathology of the Resting State in Depression

6. Development of Neuroimaging-Based Biomarkers in Major Depression

Part II. Current Diagnostic and Neurobiological Issues

7. Challenges and Strategies for Current Classifications of Depressive Disorders: Proposal for Future Diagnostic Standards

8. Epigenetics: A Missing Link Between Early Life Stress and Depression

9. From “Leaky Gut” to Impaired Glia-Neuron Communication in Depression

10. Neurogenesis and Neuroplasticity in Major Depression: Its Therapeutic Implication

11. A Load to Find Clinically Useful Biomarkers for Depression

12. Genetic Architecture of Depression: Where Do We Stand Now?

13. Pharmacogenetic/Pharmacogenomic Tests for Treatment Prediction in Depression

14. The Role of Neurotrophic Factors in Pathophysiology of Major Depressive Disorder

Part III. Current Specific Treatments for Depression

15. Clinical Application of Real-Time fMRI-Based Neurofeedback for Depression

16. Cognitive Behavioral Therapy and Mindfulness-Based Cognitive Therapy for Depressive Disorders

17. Acceptance and Commitment Therapy for Major Depressive Disorder: Insights into a New Generation of Face-to-Face Treatment and Digital Self-Help Approaches

18. Current Updates on Newer Forms of Transcranial Magnetic Stimulation in Major Depression

19. Well-being Therapy in Depressive Disorders

20. Current Research on Complementary and Alternative Medicine (CAM) in the Treatment of Major Depressive Disorder: An Evidence-Based Review

21. Psychopharmacology Algorithms for Major Depressive Disorder: Current Status

Part IV. Promising Future Treatments for Depression

22. “Novel Psychopharmacology for Depressive Disorders”

23. Creative, Person-Centered Narrative Psychopharmacotherapy of Depression

24. Induced Pluripotent Stem Cells (iPSCs) Technology: Potential Targets for Depression

25. Vaccination and Immunotherapy for Major Depression

26. Psychedelic Medicines in Major Depression: Progress and Future Challenges

27. Precision Psychiatry: Biomarker-Guided Tailored Therapy for Effective Treatment and Prevention in Major Depression